Funding Support CenterDF/HCC Sponsored FundingTimely Special Opportunity (TSO) AwardTimely Special Opportunity (TSO) Awards enhance the ability of program leaders and core directors to respond to new time-sensitive projects or opportunities that will contribute to their program or core. Projects might involve new technology development, the purchase of a piece of equipment not planned for in the annual budgeting process, or programmatic research opportunities of a timely nature. Nodal AwardsDF/HCC requests proposals for pilot projects that enhance or create new “nodal point” interactions between disease-based and discipline-based programs. Proposals for projects that further enhance the research in the area of eliminating cancer disparities will also be considered. NEW! Small Grant Program to Support Events, Conferences, and MeetingsDF/HCC has established a small grant program to fund interdisciplinary seminars, meetings, conferences, symposia, or retreats designed to encourage new interactions and collaborations among members and to stimulate the pursuit of new research areas among established collaborators. Disparities in Cancer: Faculty Diversity Funding ProgramNew Faculty Recruitment: DF/HCC provides partial funding for the recruitment of new faculty (new faculty must be eligible for DF/HCC membership) from under-represented racial/ethnic or disadvantaged backgrounds (URM) to a DF/HCC member institution. U56 Partnership Grant: DF/HCC and UMass BostonSignificant disparities exist in cancer incidence and outcomes among minority and underserved populations. The objective of the U56 Partnership between Dana-Farber/Harvard Cancer Center and the University of Massachusetts Boston is to address cancer health disparities in minority populations, and to improve research, training, and outreach opportunities for under represented minority (URM) students fellows, and faculty. Molecular and Genetic Contributions to Cancer Disparities Pilot Project AwardsThe goal of this award program is to encourage and support the development of scientific collaborations aimed at increasing our knowledge about the molecular and genetic contribution to cancer disparities. Research projects may focus on genetic (germline or somatic) or other molecular biological factors affecting disparities in cancer outcomes, incidence, response to treatment, or survival. Translational Projects In Prostate Cancer focusing on TMPRSS2 Research
The applicants (PI) must be on the faculty at Harvard Medical School or Harvard School of Public Health at the level of Assistant Professor or higher. Research may span the disciplines of basic biology, population science, or clinical science including imaging. Proposals will be accepted from investigators leading existing projects and pilot projects as well as currently non-SPORE funded investigators.
|
||